Grimes & Company’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-19,380
| Closed | -$159K | – | 309 |
|
|
2022
Q3 | $159K | Hold |
19,380
| – | – | 0.01% | 258 |
|
|
2022
Q2 | $127K | Hold |
19,380
| – | – | 0.01% | 265 |
|
|
2022
Q1 | $108K | Hold |
19,380
| – | – | 0.01% | 292 |
|
|
2021
Q4 | $91K | Sell |
19,380
-2,260
| -10% | -$10.6K | ﹤0.01% | 292 |
|
|
2021
Q3 | $134K | Buy |
+21,640
| New | +$134K | 0.01% | 293 |
|
|
2020
Q1 | – | Sell |
-2,260
| Closed | -$14K | – | 279 |
|
|
2019
Q4 | $14K | Hold |
2,260
| – | – | ﹤0.01% | 265 |
|
|
2019
Q3 | $19K | Hold |
2,260
| – | – | ﹤0.01% | 255 |
|
|
2019
Q2 | $15K | Hold |
2,260
| – | – | ﹤0.01% | 242 |
|
|
2019
Q1 | $19K | Hold |
2,260
| – | – | ﹤0.01% | 241 |
|
|
2018
Q4 | $36K | Hold |
2,260
| – | – | ﹤0.01% | 228 |
|
|
2018
Q3 | $75K | Hold |
2,260
| – | – | 0.01% | 236 |
|
|
2018
Q2 | $51K | Hold |
2,260
| – | – | ﹤0.01% | 231 |
|
|
2018
Q1 | $66K | Hold |
2,260
| – | – | 0.01% | 236 |
|
|
2017
Q4 | $63K | Hold |
2,260
| – | – | 0.01% | 212 |
|
|
2017
Q3 | $82K | Buy |
+2,260
| New | +$82K | 0.01% | 197 |
|